Dinghui Wu
Impact in
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Gout, Hyperuricemia, Uric Acid
Papers in
-
- COVID-19 Clinical Research Studies 2
- SARS-CoV-2 and COVID-19 Research 1
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 1
- Chronic Obstructive Pulmonary Disease (COPD) Research 1
- Co-authors
- Xiangyang Yao (4 shared papers)Yihua Lin (2 shared papers)Jun Lin (1 shared paper)Cheng Xue (1 shared paper)Wen Luo (2 shared papers)Wanyu Wang (2 shared papers)Jiamin Zhang (1 shared paper)Xiaoping Lin (1 shared paper)
- Journals
- Scientific Reports (1 paper)Bioscience Reports (1 paper)Canadian Respiratory Journal (1 paper)Medicine (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Dinghui Wu
6 papers receiving 25 citations
Peers
Comparison fields: 5 of 27
- Infectious Diseases 9
- Nephrology 3
- Toxicology 1
- Genetics 3
- Epidemiology 8
Countries citing papers authored by Dinghui Wu
This map shows the geographic impact of Dinghui Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dinghui Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dinghui Wu more than expected).
Fields of papers citing papers by Dinghui Wu
This network shows the impact of papers produced by Dinghui Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dinghui Wu. The network helps show where Dinghui Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Dinghui Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 9 | |
| 2 | 2020 | 7 | |
| 3 | 2024 | 3 | |
| 4 | 2021 | 3 | |
| 5 | 2022 | 2 | |
| 6 | 2022 | 1 |
About Dinghui Wu
Dinghui Wu is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine, Epidemiology, Physiology and Surgery, having authored 6 papers that have together received 25 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper), Neuroscience of respiration and sleep (1 paper), Pancreatitis Pathology and Treatment (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), Animal Virus Infections Studies (1 paper), Chronic Obstructive Pulmonary Disease (COPD) Research (1 paper) and Pneumonia and Respiratory Infections (1 paper). The work is most often cited by research in Infectious Diseases (9 citations), Nephrology (3 citations), Toxicology (1 citation), Genetics (3 citations) and Epidemiology (8 citations). Dinghui Wu has collaborated with scholars based in China and United States. Frequent co-authors include Xiangyang Yao, Yihua Lin, Jun Lin, Cheng Xue, Wen Luo, Wanyu Wang, Jiamin Zhang, Xiaoping Lin, Yiming Zeng and Wei‐Ming Su. Their work appears in journals such as Scientific Reports, Bioscience Reports, Canadian Respiratory Journal, Medicine and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.